Progression-free survival triples in select metastatic lung cancer patients with surgery or radiation after standard chemotherapy

Lung cancer patients with oliogometastases, defined as three or fewer sites of metastasis, may benefit from aggressive local therapy, surgery or radiation, after standard chemotherapy, according to research.